FDA to import more Chinese cancer drugs amid shortage

The Food and Drug Administration (FDA) is opening the way for more cancer drugs from China as the U.S. continues to deal with an ongoing shortage in key chemotherapy treatments.

A spokesperson for the FDA confirmed Monday that the agency is permitting 10 additional lots of the common cancer drug cisplatin to be distributed by the Chinese company Qilu Pharmaceutical.